510(k) Report

510(k) · Cleared

Cleared

Elecsys Testosterone Assay

K964889510(k) TraditionalCleared Mar 18, 1997102-day reviewClass I21 CFR 862.1680

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Boehringer Mannheim Corp. · CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone

Cleared on Mar 18, 1997 after a 102-day review. The summary cites one number, which could not be confirmed as its predicate (see the table below). 15 later devices descend from it.

Decided
Mar 18, 1997
Review
102 days
Class
Class I
Product code
CDZ
Recalls
None
Predicates
1

15 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2004: 1 descendant cleared2010: 1 descendant cleared2002: 1 descendant cleared2011: 1 descendant cleared2016: 3 descendants cleared2012: 1 descendant cleared2022: 1 descendant cleared2013: 1 descendant cleared2015: 1 descendant cleared2020: 1 descendant cleared2019: 2 descendants cleared2026: 1 descendant cleared1995200020052010201520202025
  1. This deviceK964889 Elecsys Testosterone AssayBoehringer Mannheim Corp. · 1997
  2. Descendant · cites it directly · 11 of its ownK093421 Elecsys Testosterone II ImmunoassayRoche Diagnostics Corp. · 2010
  3. Descendant · 2 generations on · 2 of its ownK151986 ADVA Centaur Testosterone II (TSTII), ADVA Centaur Testosterone II…Siemens Healthcare Diagnostics, Inc. · 2016
  4. Descendant · 2 generations on · 2 of its ownK120009 Testosterone Test System; Calibrator; and Quality Control Material…Abbott Laboratories · 2012
  5. Descendant · 2 generations on · 1 of its ownK211685 Elecsys Testosterone IIRoche Diagnostics · 2022
  6. Descendant · 2 generations on · 1 of its ownK122793 Liaison Testosterone; Liaison Testosterone Control SetDiaSorin, Inc. · 2013

Showing 5 of 15 descendants. See all descendants

Descendants cleared per year

2002: 12004: 12010: 12011: 12012: 12013: 12015: 12016: 32019: 22020: 12022: 12026: 1
2002high 3 (2016) · low 0 (2003)2026

Most influential descendants

Showing 5 of 15 · See all
  • K093421Elecsys Testosterone II ImmunoassayRoche Diagnostics Corp. · 2010 · cites it directly11descendants
  • K151986ADVA Centaur Testosterone II (TSTII), ADVA Centaur Testosterone II (TSTII) Master Curve…Siemens Healthcare Diagnostics, Inc. · 2016 · 2 generations on2descendants
  • K120009Testosterone Test System; Calibrator; and Quality Control Material (Assayed and Unassayed)Abbott Laboratories · 2012 · 2 generations on2descendants
  • K211685Elecsys Testosterone IIRoche Diagnostics · 2022 · 2 generations on1descendant
  • K122793Liaison Testosterone; Liaison Testosterone Control SetDiaSorin, Inc. · 2013 · 2 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K964889Elecsys Testosterone AssayBoehringer Mannheim Corp.1997—
+1K093421Elecsys Testosterone II ImmunoassayRoche Diagnostics Corp.2010—
+2K151986ADVA Centaur Testosterone II (TSTII), ADVA Centaur Testosterone II (TSTII)…Siemens Healthcare Diagnostics, Inc.2016—
+2K120009Testosterone Test System; Calibrator; and Quality Control Material (Assayed…Abbott Laboratories2012—
+2K211685Elecsys Testosterone IIRoche Diagnostics2022—
+2K122793Liaison Testosterone; Liaison Testosterone Control SetDiaSorin, Inc.2013—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200210
200410
201010
201110
201210
201310
201510
201630
201920
202010
202210
202610
FIG. 1 — Lineage of K964889, 1997–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CDZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CDZ device

  1. #1 K252728 IDS-iSYS Total Testosteronescore 11.8 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary; numbers the summary cites that cannot be its predicate are marked – and kept off the family tree.

TypeNumberDeviceApplicantDecidedRecalls
Kept off the family treeK081349Coat-A-Count® Total Testosterone Assay
Not matched in our reading of the summary (scans can blur digits), so it is kept off the family tree

What descends from it? (15)

See all 15

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K093421Elecsys Testosterone II ImmunoassayRoche Diagnostics Corp.201011
K021972Fastpack Total Testosterone ImmunoassayQualigen, Inc.20021
K041866Abbott Axsym Testosterone Microparticle Enzyme Immunoassay (Meia)Axis-Shield Diagnostics, Ltd.20040

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K093421 (Roche Diagnostics Corp., 2010) has gone furthest, with 11 descendants of its own.

How does its category compare?

All CDZ devices

CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CDZ

2in 2024

2007: 12009: 12010: 22011: 22012: 12013: 12014: 12015: 22016: 42018: 12019: 42020: 12022: 12023: 12024: 22026 (partial year): 1
2007high 4 (2016) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CDZ

141in 2019

2016: 276 days median2019: 141 days median
2007high 276 (2016) · low 141 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CDZ

1in 2025

2010: 12013: 12018: 12022: 12024: 12025: 12026 (partial year): 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CDZ

17in 2025

2007: 62008: 32009: 12010: 12011: 192012: 92013: 72014: 102015: 72016: 52017: 122018: 52019: 32020: 122021: 72022: 32023: 102024: 112025: 17
2007high 19 (2011) · low 1 (2009)2025

MAUDE reports naming product code CDZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—06
20080—03
20091—01
20102—11
20112—019
20121—09
20131—17
20141—010
20152—07
2016427605
20170—012
20181—15
2019414103
20201—012
20210—07
20221—13
20231—010
20242—111
20250—117
20261—1—

What is it indicated for?

Immunoassay for the in vitro quantitative determination of testosterone in serum and plasma.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K964889: Elecsys Testosterone Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K964889

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026